Skip to search formSkip to main contentSkip to account menu

Glipizide 10 MG Oral Tablet

Known as: GLIPIZIDE 10MG TAB [VA Product], GLIPIZIDE 10MG TAB, GLIPIZIDE 10MG TAB,UD [VA Product] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
▲ Glipizide is a second generation sulphonylurea agent that is available in a Gastrointestinal Therapeutic System (GITS) extended… 
2004
2004
Evaluation of effects of glipizide gastrointestinal therapeutic system (GITS) administered once daily (AM or PM) and… 
2004
2004
Objective To compare the blood glucose level and associated hypoglycemia risks by using insulin Glargine or human NPH both… 
2002
2002
ObjectiveThis study compared persistence on and adherence to therapy with glipizide gastrointestinal therapeutic system (GITS… 
2002
2002
OBJECTIVE Epidemiological studies have implicated increased plasminogen-activated inhibitor 1 (PAI-1) as a marker or predictor of… 
2002
2002
This study was designed to compare the pharmacokinetic and short‐term pharmacodynamic profile of extended‐release glipizide GITS… 
2002
2002
The entrapment and retention of plasma low-density lipoproteins (LDL) by arterial proteoglycans (PG) is a process central to…